HC Wainwright Trims Ovid Therapeutics (NASDAQ:OVID) Target Price to $3.00
Ovid Therapeutics (NASDAQ:OVID – Free Report) had its target price trimmed by HC Wainwright from $9.00 to $3.00 in a research note published on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. B. Riley initiated coverage on shares of Ovid Therapeutics […]
More Stories
Polaris (NYSE:PII) Reaches New 12-Month Low – What’s Next?
Polaris Inc. (NYSE:PII – Get Free Report)’s share price hit a new 52-week low on Wednesday . The company traded...
Cheniere Energy Partners (NYSE:CQP) and Cheniere Energy (NYSE:LNG) Head to Head Review
Cheniere Energy Partners (NYSE:CQP – Get Free Report) and Cheniere Energy (NYSE:LNG – Get Free Report) are both large-cap oils/energy...
Cloudflare, Inc. (NYSE:NET) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Cloudflare, Inc. (NYSE:NET – Get Free Report) have been assigned an average rating of “Hold” from the twenty-eight...
Deere & Company (NYSE:DE) Receives Average Rating of “Hold” from Brokerages
Deere & Company (NYSE:DE – Get Free Report) has been assigned a consensus rating of “Hold” from the twenty-two analysts...
Bay Capital (LON:BAY) Stock Price Up 18.5% – Here’s Why
Bay Capital Plc (LON:BAY – Get Free Report) shares rose 18.5% during mid-day trading on Wednesday . The stock traded...
Sienna Resources (CVE:SIE) Trading 16.7% Higher – Here’s Why
Sienna Resources Inc. (CVE:SIE – Get Free Report)’s stock price rose 16.7% on Wednesday . The company traded as high...